Use of nonhormonal natural products in the prevention and complex treatment of fibrocystic breast disease

According to WHO (1984), mastopathy is a fibrocystic disease (FCD) characterized by the imbalance of epithelial and connective tissue in the breast and a wide range of proliferative and regressive changes. Clinical practitioners commonly use the classification proposed by N.I. Rozhkova in 1983.

Bibliographic Details
Main Authors: D. M. Magomethanova, Z. S. Zydieva, G. S. Bоgdanova
Format: Article
Language:Russian
Published: Remedium Group LLC 2013-12-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/954
_version_ 1797841618624053248
author D. M. Magomethanova
Z. S. Zydieva
G. S. Bоgdanova
author_facet D. M. Magomethanova
Z. S. Zydieva
G. S. Bоgdanova
author_sort D. M. Magomethanova
collection DOAJ
description According to WHO (1984), mastopathy is a fibrocystic disease (FCD) characterized by the imbalance of epithelial and connective tissue in the breast and a wide range of proliferative and regressive changes. Clinical practitioners commonly use the classification proposed by N.I. Rozhkova in 1983.
first_indexed 2024-04-09T16:34:13Z
format Article
id doaj.art-3473dcfeb86745fa8532514685873fd0
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:34:13Z
publishDate 2013-12-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-3473dcfeb86745fa8532514685873fd02023-04-23T06:56:58ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902013-12-010311011310.21518/2079-701X-2013-3-110-113954Use of nonhormonal natural products in the prevention and complex treatment of fibrocystic breast diseaseD. M. Magomethanova0Z. S. Zydieva1G. S. Bоgdanova2Perinatal Center of City Clinical Hospital No. 29, MoscowPerinatal Center of City Clinical Hospital No. 29, MoscowPerinatal Center of City Clinical Hospital No. 29, MoscowAccording to WHO (1984), mastopathy is a fibrocystic disease (FCD) characterized by the imbalance of epithelial and connective tissue in the breast and a wide range of proliferative and regressive changes. Clinical practitioners commonly use the classification proposed by N.I. Rozhkova in 1983.https://www.med-sovet.pro/jour/article/view/954мастопатиярак молочной железынегормональная терапияламинариямамокламmastopathybreast cancernonhormonal therapykelpmamoclam
spellingShingle D. M. Magomethanova
Z. S. Zydieva
G. S. Bоgdanova
Use of nonhormonal natural products in the prevention and complex treatment of fibrocystic breast disease
Медицинский совет
мастопатия
рак молочной железы
негормональная терапия
ламинария
мамоклам
mastopathy
breast cancer
nonhormonal therapy
kelp
mamoclam
title Use of nonhormonal natural products in the prevention and complex treatment of fibrocystic breast disease
title_full Use of nonhormonal natural products in the prevention and complex treatment of fibrocystic breast disease
title_fullStr Use of nonhormonal natural products in the prevention and complex treatment of fibrocystic breast disease
title_full_unstemmed Use of nonhormonal natural products in the prevention and complex treatment of fibrocystic breast disease
title_short Use of nonhormonal natural products in the prevention and complex treatment of fibrocystic breast disease
title_sort use of nonhormonal natural products in the prevention and complex treatment of fibrocystic breast disease
topic мастопатия
рак молочной железы
негормональная терапия
ламинария
мамоклам
mastopathy
breast cancer
nonhormonal therapy
kelp
mamoclam
url https://www.med-sovet.pro/jour/article/view/954
work_keys_str_mv AT dmmagomethanova useofnonhormonalnaturalproductsinthepreventionandcomplextreatmentoffibrocysticbreastdisease
AT zszydieva useofnonhormonalnaturalproductsinthepreventionandcomplextreatmentoffibrocysticbreastdisease
AT gsbogdanova useofnonhormonalnaturalproductsinthepreventionandcomplextreatmentoffibrocysticbreastdisease